Table 2.
The means and distributions with standard deviations of the intraoperative and postoperative outcomes among the group that received and the group that did not receive intracameral vancomycin during cataract surgery.
| Outcome measure | Did not receive intracameral vancomycin (n = 11,333) |
Did receive intracameral vancomycin (n = 9,386) |
p value |
|---|---|---|---|
| Posterior capsular tear | Yes = 56 (0.5%) No = 11,277 (99.50%) |
Yes = 49 (0.53%) No = 9,337 (99.47%) |
p = 0.8752 |
| Anterior vitrectomy performed | Yes = 44 (0.39%) No = 11,289 (99.61%) |
Yes = 35 (0.37%) No = 9,351 (99.63%) |
p = 0.8583 |
| Dislocation of lens fragments into the posterior segment | Yes = 14 (0.13%) No = 11,319 (99.87%) |
Yes = 9 (0.10%) No = 9,377 (99.90%) |
p = 0.8463 |
| Complex procedure billed | Yes = 985 (8.7%) No = 10,348 (91.3%) |
Yes = 808 (8.6%) No = 8,578 (91.4%) |
p = 0.8488 |
| Postoperative BSCVA (logMAR) | 0.15 (0.15) | 0.13 (0.14) | p = 0.1896 |
| Postoperative endophthalmitis | Yes = 11 (0.09%) No = 11,322 (99.9%) |
Yes = 0 (0%) No =9,386 (100%) |
p = 0.0015 |